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One of the major challenges in addiction treatment is relapse prevention, as rates of relapse
following treatment remain very high across the main classes of drugs of abuse. Relapse
prevention could be improved by a better understanding of the factors that influence treat-
ment outcomes, including better predictors of risk of relapse following treatment. Recent
developments in cognitive neuroscience point to neurocognitive measures (i.e., brain-
imaging measures during cognitive-task performance) as potential predictors of relapse.
These might even be better predictors than self-report measures, such as craving. We
first give an overview of the current state of the field, and then discuss the outstanding
challenges and future directions in this area of research.
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Substance-dependent individuals often relapse, despite their
efforts to stay abstinent (1). Substance dependence is therefore
characterized as a chronic relapsing disorder (2, 3). For example,
after 1–6 months follow-up, 40–80% of the heroin- and cocaine-
dependent patients who were in treatment relapse (4–7). To
improve treatment and treatment assignment for these patients it
is important to gain knowledge about the psychological and bio-
logical processes underlying treatment outcome and relapse. The
aim of this review is to describe the use of neurocognitive measures
in addiction research in relation to the prediction of relapse, and
discuss their clinical relevance. Since there is considerable overlap
between the various substances of abuse, we attempt to focus on
factors which are known to play a role in substance-use disorders
in general (i.e., alcohol, cigarette smoking, stimulants, and opi-
ates). Where research on a specific substance is described this is
indicated.
PREDICTORS OF SUBSTANCE RELAPSE: FROM SELF-REPORT
TO NEUROCOGNITIVE MEASURES
Over the years, various kinds of predictors have been studied in
relation to substance-use relapse such as demographic character-
istics and other variables such as drug use severity, medical prob-
lems,and psychopathology [for reviews see Ref. (8,9)]. In addition,
self-report measures of emotional states such as negative affect
(10), and drug-related states such as craving (11–13) have also
found to be predictive of substance relapse [contrasting findings:
(14, 15)]. However, an important limitation of using self-report
measures is that people – and particularly substance-dependent
individuals – may have low insight into their motivations and
misrepresent their thoughts and feelings, or their reports may be
biased due to social desirability (16, 17).
Neurocognitive measures, including neurophysiological mea-
sures such as functional magnetic resonance imaging (fMRI)
and electroencephalography (EEG) during cognitive-task perfor-
mance, arguably overcome some of the limitations of self-report
measures. During neurocognitive assessments, participants are
often unaware of the purpose of the assessment. Automatic, fast
cognitive processes that are unavailable to conscious introspection
can influence behavior [e.g., Ref. (18)]. These processes cannot be
assessed via self-reports,but they can be assessed by neurocognitive
psychological assessments. In the last two decades, the use of these
neurocognitive assessments to examine neurobiological and cog-
nitive processes underlying addiction has emerged in addiction
research (19). Additionally, implicit cognitive and physiological
measures hold some promise in predicting drug relapse and may
even be better predictors than self-report measures [e.g., Ref. (13,
20–22)]; we will explore this possibility later in this review. Before
elaborating upon the association between neurocognitive mea-
sures and substance relapse, a short overview of some relevant
neurocognitive theories of addiction and supporting empirical
evidence will be provided.
NEUROCOGNITIVE PROCESSES IN ADDICTION
Various recent theories of addiction suggest an imbalance
in motivational and cognitive control processes in substance-
dependent individuals (23–27). More specifically, it is proposed
that substance-dependent individuals have an overactive motiva-
tional system that develops as a consequence of repetitive drug use.
Repetitive drug use sensitizes the mesolimbic reward system up to a
point that merely the perception (and not only the use) of drugs or
drug cues becomes salient (28). Because of this incentive salience
that is being attributed to drug-related stimuli, attention is auto-
matically oriented to these stimuli, also referred to as attentional
bias (24).
A wide range of behavioral studies have confirmed the presence
of an attentional bias to substance cues in dependent individuals
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[for review see Ref. (29)] and its association with self-reported
craving has also been supported (30). Accordingly, there has been
much interest in investigating the neurobiological substrates of
attentional bias. Recent fMRI studies showed that attentional bias
to substance cues is associated with activity in prefrontal brain
areas such as the anterior cingulate cortex (ACC) and dorsolateral
prefrontal cortex (DLPFC) (31–36), other cortical areas includ-
ing the insula (32, 35, 36) and also subcortical activation in the
nucleus accumbens (34) and amygdala (35, 37). It has been sug-
gested that these brain regions play a role in the imbalance between
motivational and control processes; that is, the nucleus accumbens
and amygdala are evidently involved in the bottom-up process of
salience attribution to substance-related stimuli while at the same
time top-down attentional resources of the prefrontal executive
areas might be impaired or depleted when focusing on cognitive
tasks in the presence of distracting drug-related cues (25, 38).
Other theories suggest that the ability to control drug use
behaviors is reduced in drug-dependent individuals, particularly
in conditions that deplete cognitive recourses, like craving or cue-
exposure (38, 39). Several studies indeed reported that cognitive
control processes, which have their neural basis in regions of the
prefrontal cortex,are impaired in substance-dependent people (25,
40, 41). Two specific cognitive control processes (i.e., inhibitory
control and error-processing) may be particularly involved in
the continuation of substance use. Inhibitory control is crucial
when one would like to control substance use by implementing
the inhibition of inappropriate behavior, while error-processing is
involved in monitoring ongoing behavior to prevent future mis-
takes. A recent review of neuroimaging studies (41) into inhibitory
control and error-processing suggests that substance dependence
is associated with reduced brain activation during inhibitory con-
trol and error-processing in the ACC, inferior frontal gyrus (IFG),
and DLPFC. In addition, event-related potentials such as the N2
and error-related negativity (ERN), reflecting brain activation
associated with inhibitory control and error-processing respec-
tively, seem to be reduced in substance-dependent patients. These
findings implicate that cognitive control processes of substance-
dependent people may be dysfunctional, thereby contributing to
the lack of control over substance-related behaviors.
In sum, both drug-related motivational processes as well as dys-
functions in cognitive control may contribute to compulsive drug
use behavior and this might explain why substance-dependent
individuals cannot control their drug use and often relapse after a
period of abstinence (23, 38, 39). Below, we will discuss studies that
have prospectively examined neurocognitive measures and their
association with substance-use outcomes. Note that all studies
described below report effects on group level; the clinical relevance
for individual patients will be discussed later in this review.
NEUROCOGNITIVE PREDICTORS OF TREATMENT OUTCOME
AND RELAPSE
Well-established research on the role of cognitive and neuro-
biological processes in addiction has resulted in an increased
focus on neurocognitive measures as predictors of treatment out-
come and relapse. On the behavioral level, results have mainly
showed an association between attentional bias and treatment
outcome in substance dependency [although some results have
been inconsistent; for a recent review see Ref. (42)]. To the best
of our knowledge, only two fMRI studies have used an attentional
bias paradigm to examine whether brain-activity related to atten-
tional bias was associated with substance relapse (36, 43). Other
fMRI studies have examined whether cue-reactivity to substance-
related stimuli might predict substance-use outcomes [(44, 45),
contrasting findings: (46); see Table 1].
Overall, the cue-reactivity studies show that enhanced brain-
activity during substance cue-exposure in prefrontal, sensory,
motor, and limbic (sub)cortical areas is associated with substance
relapse [(44, 45), cf. (46)]. Note that results in alcohol depen-
dent patients are inconsistent. Heinz et al. (46) found no relation
between neural cue-reactivity and alcohol intake after treatment.
In contrast, Beck et al. (45) found that increased prefrontal brain-
activity (during passive viewing of alcohol cues) was associated
with relapse after treatment while increased activity in the ventral
tegmental area and ventral striatum were associated with absti-
nence after treatment, indicating that different brain processes
(cognitive control vs. reward system) are differently associated
with treatment outcome in alcohol dependents.
In smokers, Janes et al. (36) found that both behavioral atten-
tional bias for smoking-related words (measured with a Stroop
task outside of the scanner) along with reactivity of the brain
to smoking cues were predictive of smoking relapse. In addition,
anterior insula and dorsal ACC (dACC) activation strongly cor-
related with respectively larger interference of drug-related words
and low accuracy during the Stroop task, suggesting that these
regions might represent the neural correlates of attentional bias
that may be important for identifying individuals at risk of relapse.
This idea is supported by a recent study showing that in cocaine-
dependent patients, increased dACC-activity related to attentional
bias for cocaine stimuli (measured with a drug Stroop task) was
associated with relapse to cocaine use after treatment (43). Thus,
it seems that the dACC – involved in salience detection and con-
flict monitoring (47–50) – plays an important role in relapse
risk. It has been suggested that hyperactivity in the dACC reflects
enhanced conflict in the presence of emotionally salient distracters,
such as substance-related stimuli. Hence, increased dACC-activity
in response to substance cues might reflect that patients at risk
of relapse need more top-down resources to focus on cognitive
tasks when substance-related cues are present as distractors dur-
ing the task. This implies that relapse-vulnerable individuals have a
reduced ability to control their substance-related cognitions, regu-
lated by the dACC, and consequently might experience difficulties
in controlling their substance-use behavior.
Studies examining the association between cognitive control
processes (e.g., inhibitory and attentional control, behavior moni-
toring) and relapse following treatment have generally found that
impaired cognitive functioning is associated with a higher risk of
relapse [for recent reviews see Ref. (51, 52)]. Only a few studies
have examined whether brain-activity related to performance on
cognitive tasks is associated with substance relapse. Paulus and
colleagues (53) were the first to report that brain-activity during a
simple two-choice task (measured with fMRI) can predict relapse
in methamphetamine dependence. This indicated that relapse
vulnerability was associated with reduced activation in a brain net-
work related to decision-making (e.g., DLPFC, parietal, temporal,
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and insular cortex). An fMRI study in cocaine-dependent patients
found that behavioral interference on the classical Stroop task and
associated brain activations in prefrontal and striatal regions are
predictive of treatment outcome, which indicates that impaired
attentional control may be a marker of relapse risk (21). Two
recent studies have examined the association between brain-
activity during error-processing and relapse in cocaine-dependent
patients [(22, 54), see also Ref. (55)]. These studies found that
reduced brain-activity during error-processing is associated with
cocaine use after treatment. More specifically, Luo et al. (54) found
that reduced thalamus, insula, and dACC-activity, measured with
fMRI, was predictive of relapse to cocaine. Marhe et al. (22) exam-
ined the ERN, an event-related potential reflecting the automatic
detection of an error. Results showed that ERN amplitudes are
associated with increased cocaine use 3 months after detoxification
treatment. These findings suggest that underactive error-related
brain-activity might be a marker of relapse risk (55).
Most of the abovementioned studies indicate that cognitive
and motivational processes are associated with relapse vulnera-
bility. This is only a first step toward clinical implementation,
and current findings need to be interpreted with caution since
group results are not necessarily valid on individual results. Dif-
ferent methodologies and designs hamper a direct comparison
between these studies. Further, it is not known whether the
results found in one substance-dependent group (e.g., cocaine-
dependent patients) can be generalized to other substances. In
addition, the treatment settings are quite diverse. However, if these
findings will stand after replication and provide more accurate
information on individual-level prediction, they might eventu-
ally help to identify substance-dependent patients that are at
risk of relapse into substance use. Obviously, this is not only
the case for neurocognitive predictors, but for all predictors
of relapse, including demographical, self-report, or behavioral
measures.
ARE NEUROCOGNITIVE MEASURES BETTER PREDICTORS OF
RELAPSE THAN SELF-REPORT MEASURES?
It is clear that neurocognitive measures such as fMRI and – to a
lesser degree – EEG are relative expensive and time consuming,
limiting their daily use in clinical practice. Therefore, in order to
advocate the use of neurocognitive measures in clinical practice,
there should be a clear advantage compared to inexpensive and
more feasible self-report predictors of relapse such as self-reported
craving and substance-use severity. One hypothetical advantage
could be that neurocognitive measures explain relapse better than
self-report measures – or at least explain additional variance in
predicting relapse over and above self-report measures.
Current relapse prediction studies addressing motivational and
cognitive control processes provide some preliminary indications
for this. Some of the studies addressing motivational aspects found
that brain-activity during substance cue-exposure was associated
with relapse, whereas self-reported craving and substance-use
severity were not associated with relapse (44–46). Marhe et al.
(43) also found that the association between attentional bias-
related brain-activity and relapse persisted when controlling for
self-reported substance-use severity. However, self-reported crav-
ing and attentional bias-related brain-activity contributed equally
to the prediction of cocaine relapse (i.e., craving explained 23%
and dACC-activity explained 22% of the variance). In addition,
studies addressing cognitive control also show additional ben-
efit of neurocognitive measures above self-reported measures.
Paulus and colleagues (53) reported that substance-use severity
was not associated with methamphetamine relapse, while brain-
activity during decision-making was. Brewer et al. (21) showed
that brain activation during Stroop interference was more strongly
related to treatment outcome than self-reported craving. Addi-
tionally, another study (22) showed that brain-activity during
error-processing was a unique predictor of cocaine relapse, over
and above substance-use severity and self-reported craving.
Hence, some relapse prediction studies indicate that neurocog-
nitive measures might make a unique contribution to the predic-
tion of relapse and may even be able to better predict outcomes
than self-report measures such as craving. In addition, regard-
ing the specific role of subjective craving, results suggest that the
relationship between neurocognitive measures and relapse is not
accounted for or mediated by craving [e.g., Ref. (42)]. Specula-
tively, they reflect two processes that might both explain variance
in relapse risk.
LIMITATION CONCERNING THE USE OF NEUROCOGNITIVE
MEASURES IN CLINICAL PRACTICE AND SUGGESTIONS FOR
FUTURE RESEARCH
Neurocognitive methods provide us with crucial information of
how brain responses are related to clinical outcomes. Although
there are some indications that neurocognitive measures could
be relevant in clinical practice there are some issues that need
further research before these measures can be applied in a clin-
ical setting. Obviously, one of the biggest challenges is moving
from group-level associations with treatment outcomes/relapse to
individual-level prediction of such outcomes, for example by using
receiver operating characteristic analyses (53, 54). This technique
provides information on the sensitivity and specificity of predic-
tors, which need to be sufficient enough to contribute to treatment
planning for an individual patient.
In the long run, neurocognitive techniques such as fMRI could
be used to investigate individual risk profiles for example with the
use of machine-learning approaches (56). However, in the short
term it is not feasible and cost-effective to scan every patient in
substance-use treatment programs using fMRI. Although the same
problems are true for EEG, it is arguably a more cost-effective and
more accessible neuroimaging tool that could be implemented
in treatment programs more easily. The idea to use EEG as a
diagnostic instrument has gained interest specifically for ERP com-
ponents that have adequate psychometric properties, such as the
ERN (57, 58). Future studies should be carried out to examine
whether routine assessment of for example ERN amplitudes in
cocaine-dependent patients [see Ref. (22)] could identify patients
vulnerable for relapse. Additionally, treatment programs could be
tailored to the patient’s need to improve outcomes. For example,
by providing specific training programs to improve cognitive [e.g.,
Ref. (59)] and/or brain functions [e.g., Ref. (60)].
Another limitation is that all studies use different measures
of treatment outcome/relapse (e.g., self-reported use or absti-
nence, urine screens, time to relapse) which makes it difficult to
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compare the present results. Using the same (multiple) outcome
measures across studies would certainly advance the field, also
beyond neurocognitive studies.
Also, current prediction studies using neurocognitive mea-
sures have not addressed the role of response inhibition, which
is another important index of cognitive control. Some evidence
comes from cross-sectional studies showing that ex-substance
users have increased brain-activity during inhibitory control
(assessed with Go-Nogo) compared to current users, suggesting
that response inhibition might underlie recovery from substance
dependence [smokers: (34); cocaine users: (61)]. Future stud-
ies should address the predictive role of response inhibition in
prospective designs.
Finally, it is of theoretical as well as clinical importance
that studies investigating the predictive value of neurocognitive
processes of addiction include self-report and behavioral measures
in prediction models. It is important to test whether the unique
contribution of these relatively “new” measures is high enough in
addition to well-established, more easily administered measures.
Ideally, relapse prediction models should be multifactorial and
should include (socio)demographic, psychological, physiological,
and cognitive variables. Of course, large sample sizes are needed
to accomplish sufficient power (62).
CONCLUSION
Neuroimaging research has yielded important information on
neurocognitive mechanisms of substance dependence in relation
to treatment processes and outcome. Results have shown that
neurocognitive measures can provide information on relapse vul-
nerability over and above the information gained from self-report
measures such as craving on a group level. However, regarding
clinical utility it is important that all prediction studies report
the sensitivity and specificity of neurocognitive relapse predictors.
This will allow gaining more knowledge on the suitability of neu-
rocognitive measures for individual risk taxation, necessary for
implementation in clinical settings.
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